Alberto Trovato

Alberto Trovato

Auto-generated profile, based on publicly available information

Alberto Trovato

Emerging Bacterial Pathogens Unit, IRCCS San Raffaele Scientific Institute, Milano, Italy

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2016 in International Journal of Systematic and Evolutionary Microbiology
Verified
Journal Article
Closed access
ETEnrico Tortoli
Enrico Tortoli
TKThomas A. Kohl
Thomas A. Kohl
BBBarbara A. Brown-Elliott
Barbara A. Brown-Elliott
ATAlberto Trovato
Alberto Trovato
SLSylvia Cardoso Leão
Sylvia Cardoso Leão
DCDaniela M. Cirillo
Daniela M. Cirillo
The taxonomic position of members of the Mycobacterium abscessus complex has been the subject of intensive investigation and, in some aspects confusion, in recent years as a result of varying approaches to genetic data interpretation. Currently, the former species Mycobacterium massiliense and Mycobacterium bolletii are grouped together as Mycobacterium abscessus subsp. bolletii . They differ greatly, however, as the former M. bolletii has a functional erm(41) gene that confers inducible resistance to macrolides, the primary therapeutic antimicrobials for M. abscessus , while in the former M. massiliense the erm(41) gene is non-functional. Furthermore, previous whole genome studies of the M. abscessus group support the separation of M. bolletii and M. massiliense . To shed further light on the population structure of Mycobacterium abscessus , 43 strains and three genomes retrieved from GenBank were subjected to pairwise comparisons using three computational approaches: verage ucleotide dentity, enome to enome istance and single nucleotide polymorphism analysis. The three methods produced overlapping results, each demonstrating three clusters of strains corresponding to the same number of taxonomic entities. The distances were insufficient to warrant distinction at the species level, but met the criteria for differentiation at the subspecies level. Based on prior erm(41)-related phenotypic data and current genomic data, we conclude that the species M. abscessus encompasses, in adjunct to the presently recognized subspecies M. abscessus subsp. abscessus and M. abscessus subsp. bolletii , a third subspecies for which we suggest the name M. abscessus subsp. massiliense comb. nov. (type strain CCUG 48898T=CIP 108297T=DSM 45103T=KCTC 19086T).

1 December 2017 in Infection, Genetics and Evolution
Verified
Journal Article
Closed access
ETEnrico Tortoli
Enrico Tortoli
TFTarcisio Fedrizzi
Tarcisio Fedrizzi
CMConor J. Meehan
Conor J. Meehan
ATAlberto Trovato
Alberto Trovato
AGAntonella Grottola
Antonella Grottola
DCDaniela Cirillo
Daniela Cirillo

1 November 2019 in Infection, Genetics and Evolution
Verified
Journal Article
Closed access
ETEnrico Tortoli
Enrico Tortoli
CMConor J. Meehan
Conor J. Meehan
AGAntonella Grottola
Antonella Grottola
GSGiulia Fregni Serpini
Giulia Fregni Serpini
AFAnna Fabio
Anna Fabio
DCDaniela M. Cirillo
Daniela M. Cirillo

13 April 2016 in Journal of Antimicrobial Chemotherapy
Verified
Journal Article
Open access
PDF file
ESElisa Schena
Elisa Schena
LNLubov Nedialkova
Lubov Nedialkova
EBEmanuele Borroni
Emanuele Borroni
SBSimone Battaglia
Simone Battaglia
ACAndrea Maurizio Cabibbe
Andrea Maurizio Cabibbe
DCDaniela Cirillo
Daniela Cirillo
The objective of this study was to develop standardized protocols for rapid delamanid drug susceptibility testing (DST) using the colorimetric resazurin microtitre assay (REMA) and semi-automated BACTEC™ MGIT™ 960 system (MGIT) by establishing breakpoints that accurately discriminate between susceptibility and resistance of Mycobacterium tuberculosis to delamanid. MICs of delamanid were determined by the MGIT, the REMA and the solid agar method for 19 pre-characterized strains. The MIC distribution of delamanid was then established for a panel of clinical strains never exposed to the drug and characterized by different geographical origins and susceptibility patterns. WGS was used to investigate genetic polymorphisms in five genes (ddn, fgd1, fbiA, fbiB and fbiC) involved in intracellular delamanid activation. We demonstrated that the REMA and MGIT can both be used for the rapid and accurate determination of delamanid MIC, showing excellent concordance with the solid agar reference method, as well as high reproducibility and repeatability. We propose the tentative breakpoint of 0.125 mg/L for the REMA and MGIT, allowing reliable discrimination between M. tuberculosis susceptible and resistant to delamanid. Stop codon mutations in ddn (Trp-88 → STOP) and fbiA (Lys-250 → STOP) have only been observed in strains resistant to delamanid. We established protocols for DST of delamanid in the MGIT and REMA, confirming their feasibility in routine TB diagnostics, utilizing the same discriminative concentration for both methods. Moreover, taking advantage of WGS analysis, we identified polymorphisms potentially associated with resistance in two genes involved in delamanid activation.

13 June 2017 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
BABenon B. Asiimwe
Benon B. Asiimwe
RBRossella Baldan
Rossella Baldan
ATAlberto Trovato
Alberto Trovato
DCDaniela Cirillo
Daniela Cirillo
Staphylococcus aureus strains are now regarded as zoonotic agents. In pastoral settings where human-animal interaction is intimate, multi-drug resistant microorganisms have become an emerging zoonotic issue of public health concern. The study of S. aureus prevalence, antimicrobial resistance and clonal lineages in humans, animals and food in African settings has great relevance, taking into consideration the high diversity of ethnicities, cultures and food habits that determine the lifestyle of the people. Little is known about milk carriage of methicillin resistant S. aureus strains (MRSA) and their virulence factors in Uganda. Here, we present the prevalence of MRSA in bulk can milk and raw milk products in pastoral communities of south-west Uganda. We also present PFGE profiles, spa-types, as well as frequency of enterotoxins genes. S. aureus was identified by the coagulase test, susceptibility testing by the Kirby-Bauer disc diffusion and E-test methods and MRSA by detection of the mecA gene and SCCmec types. The presence of Panton – Valentine Leucocidin (PVL) genes and staphylococcal enterotoxins was determined by PCR, while genotyping was by PFGE and spa typing. S. aureus were isolated from 30/148 (20.3%) milk and 11/91(12%) sour milk samples. mecA gene carriage, hence MRSA, was detected in 23/41 (56.1%) of the isolates, with 21 of the 23 (91.3%) being SCCmec type V; while up to 30/41 (73.2%) of the isolates were resistant to tetracycline. Only five isolates carried the PVL virulence gene, while PFGE typing revealed ten clusters (ranging from two seven isolates each) that comprised 83% of the sample, and only eight isolates with unique pulsotypes. The largest PFGE profile (E) consisted of seven isolates while t7753, t1398, and t2112 were the most common spa-types. Thirty seven of the 41 strains (90.2%) showed at least one of the eight enterotoxin genes tested, with sem 29 (70.7%), sei 25 (61%) and seg 21 (51.2%) being the most frequently observed genes. This is the first study to demonstrate MRSA and enterotoxin genes in raw milk and its products in Uganda. The fact that over 90% of the isolates carried at least one gene encoding enterotoxins shows a high risk of spread of foodborne diseases through milk in this setting.

1 September 2019 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Open access
PDF file
AGArash Ghodousi
Arash Ghodousi
ARAlamdar Hussain Rizvi
Alamdar Hussain Rizvi
ABAurangzaib Quadir Baloch
Aurangzaib Quadir Baloch
AGAbdul Ghafoor
Abdul Ghafoor
FKFaisal Masood Khanzada
Faisal Masood Khanzada
DCDaniela Cirillo
Daniela Cirillo
We report on the first six cases of acquired resistance to bedaquiline in Pakistan. Seventy sequential isolates from 30 drug-resistant-tuberculosis patients on bedaquiline-containing regimens were retrospectively tested for bedaquiline resistance by MIC testing and by the detection of mutations in relevant genes. We documented cases failing therapy that developed specific mutations in Rv0678 and had increased MICs associated with cross-resistance to clofazimine during treatment.